FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Vincristine Sulfate (VINCASAR PFS) Injection, USP
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Teva Pharmaceuticals (New 07/05/2019)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
VINCASAR PFS (vincristine sulfate injection USP) 2 mg/2 mL Vial (1 mg/mL) (NDC 0703-4412-11) N/A Teva made a business decision to discontinue this product size (2mL).
Vincasar PFS -- vincristine sulfate injection, solution, 1 MG/ 1 ML (NDC 0703-4402-11) 07/05/2019 Teva made a business decion to discontinue the product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English